{"id":"NCT00633893","sponsor":"Bristol-Myers Squibb","briefTitle":"Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism","officialTitle":"A Safety and Efficacy Trial Evaluating the Use of Apixaban for the Extended Treatment of Deep Vein Thrombosis and Pulmonary Embolism","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-05","primaryCompletion":"2012-08","completion":"2012-08","firstPosted":"2008-03-12","resultsPosted":"2013-10-25","lastUpdate":"2013-11-25"},"enrollment":2711,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Venous Thrombosis"],"interventions":[{"type":"DRUG","name":"Apixaban","otherNames":["BMS-562247"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"EXPERIMENTAL"},{"label":"3","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose is to evaluate the effects of an investigational blood thinner, apixaban, in preventing venous thromboembolic (VTE) recurrence or death in patients who have completed their intended treatment for deep vein thrombosis (DVT) or pulmonary embolism (PE)","primaryOutcome":{"measure":"Adjudicated Composite of Symptomatic, Recurrent Venous Thromboembolism (VTE) or All-Cause Death During the Intended Treatment Period - Randomized Population With Imputation","timeFrame":"Day 1 up to 12 Months","effectByArm":[{"arm":"Apixaban 2.5 mg","deltaMin":0.0381,"sd":null},{"arm":"Apixaban 5 mg","deltaMin":0.0418,"sd":null},{"arm":"Placebo","deltaMin":0.1158,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG001 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":5},"locations":{"siteCount":428,"countries":["United States","Argentina","Australia","Austria","Brazil","Canada","Chile","Czechia","Denmark","France","Germany","Hong Kong","India","Israel","Italy","Mexico","Norway","Philippines","Poland","Portugal","Puerto Rico","Romania","Russia","Singapore","South Africa","South Korea","Spain","Ukraine","United Kingdom"]},"refs":{"pmids":["35570249","26446706","23216615"],"seeAlso":["http://www.bms.com/clinical_trials/Pages/Investigator_Inquiry_form.aspx"]},"adverseEventsSummary":{"seriousAny":{"events":112,"n":840},"commonTop":["PAIN IN EXTREMITY","HEADACHE","NASOPHARYNGITIS","BACK PAIN","URINARY TRACT INFECTION"]}}